PTC Therapeutics
PTCT
#3037
Rank
A$7.61 B
Marketcap
A$91.28
Share price
0.08%
Change (1 day)
-7.31%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.99 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is A$0.99 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$4.04 B1.73%
2024-12-31A$3.97 B21.42%
2023-12-31A$3.27 B52.34%
2022-12-31A$2.14 B22.66%
2021-12-31A$1.75 B220.22%
2020-12-31A$0.54 B16.7%
2019-12-31A$0.46 B115.71%
2018-12-31A$0.21 B16.97%
2017-12-31A$0.18 B36.28%
2016-12-31A$0.13 B8.07%
2015-12-31A$0.12 B
2014-12-31N/A-100%
2013-12-31A$0.05 M-98.83%
2012-12-31A$4.69 M-58.78%
2011-12-31A$11.4 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$70.23 B 6,937.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$2.83 B 183.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.24 B-75.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.49 B 50.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.10 B-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$70.57 M-92.93%๐Ÿ‡บ๐Ÿ‡ธ USA